Cost-Effectiveness of Lowering Cholesterol in Older Patients after Heart Attack

Abstract

Summaries for Patients16 May 2000Cost-Effectiveness of Lowering Cholesterol in Older Patients after Heart AttackSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-132-10-200005160-00037 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Statins are drugs used to lower cholesterol levels. Use of statin therapy to lower cholesterol levels in patients younger than 75 years of age who have had a previous heart attack (secondary prevention) is well accepted in the medical community. However, the use of statins in patients older than 75 years of age has not been well studied. Thus, little is known about the costs and benefits of secondary prevention with statins for patients in this age group.Why did the researchers do this particular study?To find ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “ Cost-Effectiveness of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Therapy in Older Patients with Myocardial Infarction.” It is in the 16 May 2000 issue of Annals of Internal Medicine (volume 132, pages 780-787). The authors are D.A. Ganz, K.M. Kuntz, G.A. Jacobson, and J. Avorn.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCost-Effectiveness of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Therapy in Older Patients with Myocardial Infarction David A. Ganz , Karen M. Kuntz , Gretchen A. Jacobson , and Jerry Avorn Metrics 16 May 2000Volume 132, Issue 10Page: 780KeywordsAge groupsCholesterolDrugsLongitudinal studiesMedical risk factorsMyocardial infarctionQuality adjusted life yearsSimulation and modelingStatinsStroke ePublished: 15 August 2000 Issue Published: 16 May 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.Loading ...